Could Eledon’s Anti-CD40L Change Transplant Medicine?

 
• By David Wild
  
Eledon CEO Hopes Tegoprubart Will Be The Cornerstone Of Transplant Immunosuppression • Source: Shutterstock
In Vivo Podcast

Candid conversations with C-suite leaders.

Keep up with strategy, innovation and evolving trends across life science industries.

SpotifyApple PodcastsWebsite

More from Innovation

More from In Vivo